세계의 경장영양 디바이스 시장 규모는 2023년에 29억 3,000만 달러에 달했습니다. 이 시장은 2024-2030년의 예측 기간 중 6.62%의 CAGR로 확대하며, 2030년에는 43억 달러에 달할 것으로 예측됩니다. 경장영양 디바이스 시장 전체는 서로 관련된 몇개의 요인에 의해 크게 촉진되고 있습니다. 암, 당뇨병, 신경 장애와 같은 만성질환의 유병률 증가로 인해 환자가 음식을 정상적으로 섭취하거나 소화하는 능력이 손상되어 경장 영양에 대한 실질적인 필요성이 대두되고 있습니다. 또한 장기적인 영양 관리가 필요한 환자의 입원 건수가 증가함에 따라 병원이 환자의 영양 관리를 위한 효과적인 솔루션을 찾고 있는 것도 이러한 장비의 필요성을 더욱 높이고 있습니다. 동시에 주요 시장 진입 업체들의 제품 개발 활동이 급증하면서 혁신적이고 개선된 경장영양 솔루션을 도입하여 시장을 강화하고 있습니다. 따라서 이러한 요인들은 2024-2030년의 예측 기간 중 경장 영양 장비 시장을 촉진할 것으로 예상됩니다.
GLOBOCAN이 제공한 데이터에 따르면 2022년 전 세계에서 새로 발생한 뇌 및 중추신경계 암 환자 수는 322,000명으로 추산되며, 2045년까지 474,000명 증가할 것으로 예상됩니다. 뇌 및 중추신경계(CNS) 암은 환자의 섭식 및 소화 능력에 영향을 미치기 때문에 경장영양 디바이스 시장을 크게 성장시킬 수 있습니다. 뇌와 척수에 영향을 미치는 종양은 운동 기능, 인지 능력, 삼킴 메커니즘을 손상시켜 경구로 적절한 영양을 섭취하는 데 상당한 어려움을 겪게 됩니다. 따라서 경장영양 디바이스는 필요한 영양 지원을 제공하고 전반적인 건강을 유지하는 데 필수적이어서 전체 경장영양 디바이스 시장이 확대되고 있습니다.
모든 지역 중 북미는 2023년 경장영양 디바이스 세계 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다. 북미 경장 영양 장비 시장은 지역 전체의 조산, 만성질환 및 입원 증가와 같은 여러 요인으로 인해 성장세를 보이고 있습니다. 또한 북미 경장 영양 장비 시장 시장 확대에 관여하는 주요 시장 진출기업의 존재는 지역 전체에서 고급 치료 및 기술에 대한 수요 증가에 대응하고 있습니다.
세계의 경장영양 디바이스 시장에 대해 조사했으며, 시장의 개요와 제품 유형별, 연령층별, 용도별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.
Enteral Feeding Devices Market by Product Type (Enteral Feeding Pumps, Enteral Feeding Tubes [Enterostomy Feeding Tubes, Oroenteric Feeding Tubes, Nasoenteric Feeding Tubes {Nasogastric Feeding Tubes, Nasojejunal Feeding Tubes, and Nasoduodenal Feeding Tubes}, and Others], Enteral Syringes, Gravity Sets, and Others), Age Group (Adults and Pediatrics), Application (Gastroenterology, Critical Care, Neurology, Oncology, and Others), By End-User (Hospitals, Ambulatory Surgical Centers (ASC), Emergency Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of chronic disease such as cancer, diabetes, and neurological disorders, increase in hospital admission, and increase in product developmental activities by the key market players across the globe.
The global enteral feeding devices market was valued at USD 2.93 billion in 2023, growing at a CAGR of 6.62% during the forecast period from 2024 to 2030, to reach USD 4.30 billion by 2030. The overall market for enteral feeding devices is significantly boosted by several interrelated factors. The rising prevalence of chronic diseases such as cancer, diabetes, and neurological disorders creates a substantial need for enteral nutrition due to the impaired ability of affected individuals to consume or digest food normally. Additionally, the growing number of hospital admissions of patients requiring extended nutritional care further propels the need for these devices, as hospitals seek effective solutions for managing patient nutrition. Concurrently, the surge in product development activities by key market players enhances the market by introducing innovative and improved enteral feeding solutions. Thus, these factors are expected to boost the market of enteral feeding devices during the forecast period from 2024 to 2030.
Enteral Feeding Devices Market Dynamics:
According, to the data provided by the GLOBOCAN, in 2022 globally, the estimated new cases of brain and central nervous system cancer was 322,000 and the projection were indicated to increase 474,000 by 2045. Brain and central nervous system (CNS) cancers can significantly boost the market for enteral feeding devices due to the impact these conditions have on a patient's ability to eat and digest food. Tumors affecting the brain or spinal cord can impair motor functions, cognitive abilities, and the swallowing mechanism, often leading to severe difficulties in consuming adequate nutrition orally. As a result, enteral feeding devices become essential for providing necessary nutritional support and maintaining overall health therefore escalating the overall market of eternal feeding devices.
Furthermore, according, to the latest data provided by the Australian Institute of Health and Welfare (2023), there were 12.1 million hospitalizations in 2022 to 2023. Additionally, hospitalizations increased by 4.6% compared with 2021 to 2022 from 11.6 million to 12.1 million. The rise in hospital admissions, particularly due to chronic illnesses, surgeries, and critical care needs, is significantly boosting the market for enteral feeding devices. Patients admitted for conditions like stroke, cancer, gastrointestinal disorders, and neurological impairments often face difficulties with oral intake and require enteral feeding for adequate nutrition. Additionally, intensive care units (ICUs) frequently use enteral feeding tubes to maintain nutritional support for patients under sedation or on ventilators. With hospitals handling a larger volume of elderly patients and those with complex conditions, the demand for feeding devices such as nasogastric tubes, gastrostomy tubes, and enteral feeding pumps is growing.
Further, the increase in product development activities across the globe is further boosting the overall market of enteral feeding devices. For instance, in September 2021, Vonco Products LLC received FDA 510(k) clearance for Novel Closed-Loop Enteral Feeding Solution - EnteraLoc(TM) Flow.
Thus, the factors mentioned above are likely to boost the market of enteral feeding devices during the forecasted period.
However, accidental dislodgment of tubes resulting in disabilities that can prove to be fatal and risk of infection associated with enteral feeding devices may hinder the future market of enteral feeding devices.
Enteral Feeding Devices Market Segment Analysis:
Enteral Feeding Devices Market by Product Type (Enteral Feeding Pumps, Enteral Feeding Tubes [Enterostomy Feeding Tubes, Oroenteric Feeding Tubes, Nasoenteric Feeding Tubes {Nasogastric Feeding Tubes, Nasojejunal Feeding Tubes, and Nasoduodenal Feeding Tubes}, and Others], Enteral Syringes, Gravity Sets, and Others), Age Group (Adults and Pediatrics), Application (Gastroenterology, Critical Care, Neurology, Oncology, and Others), By End-User (Hospitals, Ambulatory Surgical Centers (ASC), Emergency Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the enteral feeding devices market, enteral feeding pumps are projected to hold a considerable market share in 2023. Enteral feeding pumps are significantly boosting the overall market for enteral feeding devices by offering advanced solutions that enhance the efficiency, precision, and safety of nutritional delivery. These pumps automate the feeding process, allowing for precise control over the flow rate and volume of enteral nutrition, which helps to improve patient outcomes and reduce the risk of complications such as aspiration or overfeeding. The integration of advanced technologies in enteral feeding pumps, such as programmable settings, alarms for potential issues, and connectivity for remote monitoring, addresses the growing demand for more reliable and user-friendly feeding solutions. Additionally, the increasing adoption of home healthcare services drives the need for portable and easy-to-use feeding pumps, expanding their market reach. As healthcare providers and patients alike seek more effective ways to manage long-term nutritional needs, the enhanced capabilities and convenience of enteral feeding pumps play a crucial role in driving market growth and expanding the range of available feeding solutions.
Furthermore, the increasing product developmental activities in enteral feeding pumps across the globe are further propelling the market of the segment. For instance, in February 2021, Amsino Medical Group announced the US FDA 510(k) clearance for the Puggle(R) Enteral Feeding Pump and Set. The PUGGLE(R) Enteral Feeding Pump and Feeding Set are intended to deliver nutrition to both the pediatric and adult feeding tube patient population. Therefore, owing to the above-mentioned factors, the enteral feeding pumps devices category is expected to generate considerable revenue thereby pushing the overall growth of the global enteral feeding devices market during the forecast period.
North America is expected to dominate the overall enteral feeding devices market:
Among all the regions, North America is expected to hold the largest share in the global enteral feeding devices market in 2023. The enteral feeding devices market in North America is witnessing growth due to several factors like increase in preterm birth, chronic diseases, and hospital admission across the region. Additionally, the presence of key market players involved in the market expansion of enteral feeding devices market in North America, catering to the increasing demand for advanced treatments and technologies across the region.
According, to the recent data provided by Pan American Health Organization (2023), in the United States, approximately 152 million babies were born preterm in last decade. Babies born before 37 weeks of gestation often face challenges such as underdeveloped gastrointestinal tracts, difficulty in sucking or swallowing, and an increased risk of malabsorption. Enteral feeding devices are crucial in providing these infants with the necessary nutrients to support growth and development while bypassing the difficulties of oral feeding. The demand for enteral feeding solutions tailored to neonates, such as neonatal feeding tubes and pumps, drives innovation and market expansion.
Additionally, according to the American Hospital Association's (2024), in 2022 Annual Survey reports states that U.S. hospitals had a total of 33,679,935 hospital admissions. Increased hospital admissions and the prevalence of hospital-acquired infections (HAIs) can significantly boost the market for enteral feeding devices by heightening the demand for effective nutritional support solutions. Hospitalized patients often require enteral feeding due to various conditions that impair their ability to eat or digest food, including complications from HAIs. As infections prolong hospital stays and complicate patient care, the need for enteral feeding devices to manage nutritional intake becomes more pronounced thereby boosting the overall market across the region.
Furthermore, recent merger, acquisitions, positive clinical trials, and product approvals among key market players in the region further propels the market across the region. For example, In November 2022, Rockfield Medical Devices Limited, a commercial-stage medical device company, announced that it received FDA 510(k) clearance for its Mobility+ Enteral Feeding System. The device was designed to enhance the mobility and quality of life for tube feeders.
Therefore, the factors mentioned above are expected to boost the growth of the enteral feeding devices market in the North American region during the forecast period from 2024 to 2030.
Enteral Feeding Devices Market Key Players:
Some of the key market players operating in the enteral feeding devices market include Fresenius SE & Co. KgaA, Boston Scientific Corporation, Cook Medical, Inc., Cardinal Health Inc., Becton, Dickinson, and Company, Moog Inc., B. Braun Melsungen AG, Amsino International, Inc., Nestle Health Science, Avanos Medical, Inc., Abbott Laboratories, CONMED Corporation, CORPAK, Covidien PLC, ALCOR Scientific Inc., Applied Medical Technology, Inc., Vygon, Danone, Enteral Access Technologies Ltd., Medline Industries, LP, and others.
Recent Developmental Activities in the Enteral Feeding Devices Market:
Key Takeaways From the Enteral Feeding Devices Market Report Study:
Target Audience who can be Benefited From This Enteral Feeding Devices Market Report Study:
Frequently Asked Questions for the Enteral Feeding Devices Market: